Other
Endometritis
12
Pipeline Programs↗
4
Active Trials↗
4
Companies Involved↗
Endometritis is an emerging landscape with 12 programs across 4 companies. The most active players are Pfizer, Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. 4 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 1
No programs
Phase 22
Phase 3
No programs
Analysis
Trial Status
14
clinical trials
Completed7 · 50%
Not yet recruiting2 · 14%
Unknown status2 · 14%
Recruiting2 · 14%
Withdrawn1 · 7%
Clinical Trials
Trial Activity
14 trials
Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF)
Recruiting·—·N/A·NCT07488949·1,000 enrolled
Randomized Controlled Trial of Berberine in Combination With Doxycycline in the Treatment of Chronic Endometritis
Recruiting·TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine·Phase 1/2·NCT07180563·206 enrolled
Efficacy of Dead Sea Peloid Gel in Chronic Endometritis
Completed·SScientific Center for Family Health and Human Reproduction Problems, Russia·N/A·NCT02680275·30 enrolled
RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis
Completed·—·N/A·NCT02648698·120 enrolled
Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis
Unknown status·—·Phase 4·NCT02693483·306 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)